Raymond James: Fate Therapeutics & Ocata Expected To Beat Market

By: via Benzinga
Fate Therapeutics Inc (NASDAQ: FATE) shares are down 5 percent since July 7, while shares of Ocata Therapeutics Inc (NASDAQ: ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.